Why Fatty Liver Disease Remains a Silent Health Threat

The condition, now clinically termed MASLD, frequently progresses without the patient feeling ill. This asymptomatic nature makes routine screenings vital for those navigating metabolic risk factors, including obesity, pre-diabetes, type 2 diabetes, and high blood pressure. When left untreated, this fat buildup can evolve into chronic inflammation, fibrosis, and eventually life-threatening cirrhosis or liver failure.

Diagnosis typically begins with blood work to check for elevated liver enzymes, followed by imaging studies like ultrasounds or CT scans to visualize internal changes. Dr. Jerome-Zapadka emphasizes that early identification is a critical window for intervention. By addressing insulin resistance through structured weight loss, increased physical activity, and a reduction in sugar and carbohydrate intake, patients can often reverse fat accumulation before the onset of permanent tissue scarring. Proactive screening remains the most effective tool to prevent these long-term complications in high-risk populations.